Spinning a solution in healthcare from a basic technology requires phased research from basic to translational, pre-clinical and clinical studies, for which Japan has a wholesome ecosystem; GN Corp track record, interviewed for a feature story, sponsored by Government of Japan, published in Bloomberg.
Cell therapy solutions for corneal epithelial and endothelial diseases of GNCorp forge an alliance with Indian and African healthcare institutes
23/8/2025
DMI group of institutes in India, Tanzania, Malawi and Zambia to start basic to translational research August
